We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$945M
AUM Growth
+$260K
Cap. Flow
-$10.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
30.13%
Holding
252
New
4
Increased
45
Reduced
95
Closed
8

Top Buys

Rank Stock Value
1
BX icon
Blackstone
BX
+$3.76M
2
CVS icon
CVS Health
CVS
+$2.55M
3
VZ icon
Verizon
VZ
+$991K
4
JNJ icon
Johnson & Johnson
JNJ
+$831K
5
DIS icon
Walt Disney
DIS
+$674K

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$3.9M
2
WFC icon
Wells Fargo
WFC
+$1.56M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$960K
4
CTVA icon
Corteva
CTVA
+$881K
5
IAT icon
iShares US Regional Banks ETF
IAT
+$728K

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Technology 15.01%
3 Financials 14.74%
4 Industrials 13.25%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MER.PRK
201
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$210K 0.02%
8,000
– –
WBA
202
DELISTED
Walgreens Boots Alliance
WBA
$202K 0.02%
+3,644
New +$195K
HSY icon
203
Hershey
HSY
$36.6B
$201K 0.02%
+1,300
New +$196K
FCX icon
204
Freeport-McMoran
FCX
$97.5B
$182K 0.02%
19,009
– –
NRT
205
North European Oil Royalty Trust
NRT
$81M
$171K 0.02%
27,999
-1,200
-4% -$8.27K
MRKR icon
206
Marker Therapeutics
MRKR
$18.7M
$154K 0.02%
3,010
– –
NTRP
207
DELISTED
Neurotrope, Inc. Common
NTRP
$89K 0.01%
109,375
– –
WHWK
208
Whitehawk Therapeutics
WHWK
$271M
$68K 0.01%
6,667
– –
XCUR icon
209
Exicure
XCUR
$8.54M
$42K ﹤0.01%
+111
New +$42.4K
MTNB icon
210
Matinas BioPharma
MTNB
$1.81M
$11K ﹤0.01%
350
– –
LLY icon
211
Eli Lilly
LLY
$1.06T
– –
-2,200
Closed -$244K
NFLX icon
212
Netflix
NFLX
$309B
– –
-5,500
Closed -$202K
OVV icon
213
Ovintiv
OVV
$16.4B
– –
-2,118
Closed -$54K
TAK icon
214
Takeda Pharmaceutical
TAK
$55.7B
– –
-21,609
Closed -$383K
BBT.PRD.CL
215
DELISTED
BB&T CORPORATION Depositary Shares, representing 1/1,000th interest in a share of Series D Non-Cumul
BBT.PRD.CL
– –
-14,800
Closed -$374K
BBT.PRE.CL
216
DELISTED
BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C
BBT.PRE.CL
– –
-8,000
Closed -$201K
APC
217
DELISTED
Anadarko Petroleum
APC
– –
-55,232
Closed -$3.9M
HGT
218
DELISTED
Hugoton Royalty Trust
HGT
– –
-17,500
Closed -$6K
5 6 7 8
9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q3 2019 Portfolio in Review

As of Q3 2019, Neville Rodie & Shaw held 252 positions worth $945M, up 0.03% from $945M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.8%. Neville Rodie & Shaw opened 4 new positions and exited 8, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q3 2019 buy was Occidental Petroleum: 11,277 shares worth $501K.
  • Neville Rodie & Shaw added most to Blackstone in Q3 2019, an estimated $3.76M increase.
  • Neville Rodie & Shaw's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $1.56M.
  • Neville Rodie & Shaw fully exited Anadarko Petroleum in Q3 2019, selling an estimated $3.9M.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $945M portfolio in Q3 2019.
  • Neville Rodie & Shaw opened 4 new positions and closed 8 in Q3 2019.
  • Neville Rodie & Shaw's portfolio value rose 0.03% quarter-over-quarter to $945M.

Based on Neville Rodie & Shaw's 13F filing for Q3 2019, filed 2 Oct 2019.